Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
about
High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocolOutcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.Association of ITPA genotype with event-free survival and relapse rates in children with acute lymphoblastic leukemia undergoing maintenance therapyA phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhoPostrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group.Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemiaPediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.Screening for gene mutations: will identification of NT5C2 mutations help predict the chance of relapse in acute lymphoblastic leukemia?Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study.A novel AGGF1-PDGFRb fusion in pediatric T-cell acute lymphoblastic leukemia."The Second Time is Sweeter After All".Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress.Disulfide-stabilized diabody antiCD19/antiCD3 exceeds its parental antibody in tumor-targeting activity.Prognosis and outcome of relapsed acute lymphoblastic leukemia: A Hong Kong pediatric hematology and Oncology Study Group report
P2860
Q23749304-CA64B5FE-32A1-476B-92C2-492C30E350F2Q33628794-E5032918-B307-4FBE-9A93-19E3F1B76F0CQ34323258-735A27E7-BC88-4BE4-82C5-5B3A77AD0292Q34547528-5BC01AD5-9E49-483A-840D-DFF36CE78C6DQ34707213-7BA75391-3D73-4611-967E-D49E7B21AC82Q36276060-32341D5E-1CCB-41ED-A43B-D2E20B00FDDCQ38097334-FEA797BE-21A1-44FE-A24D-C5AD2B98607CQ41976584-0DD199BE-D021-4876-B0A2-2BEBA42BF758Q49497206-86E731BF-F3CC-4321-A0FF-D482B6F40423Q50327439-D79FCCE6-1C43-4E2A-8A0B-206DF13F430DQ50919950-1C150DE1-46E0-40CF-8FAE-FCD691787EAAQ53814000-8BEED0CC-A8E4-46D2-8E4E-6A372C967626Q54325947-DAE51BD9-6B23-4F5A-909B-EBF9DE2309B5Q59103913-6391B782-CB80-48A5-A224-6812092B2408
P2860
Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Long-term outcome of initially ...... urt-Münster (BFM) Study Group.
@en
Long-term outcome of initially ...... trian Berlin-Frankfurt-Münster
@nl
type
label
Long-term outcome of initially ...... urt-Münster (BFM) Study Group.
@en
Long-term outcome of initially ...... trian Berlin-Frankfurt-Münster
@nl
prefLabel
Long-term outcome of initially ...... urt-Münster (BFM) Study Group.
@en
Long-term outcome of initially ...... trian Berlin-Frankfurt-Münster
@nl
P2093
P1476
Long-term outcome of initially ...... urt-Münster (BFM) Study Group.
@en
P2093
Andishe Attarbaschi
Austrian Berlin-Frankfurt-Münster (BFM) Study Group
Bernhard Meister
Bettina Reismüller
Christian Urban
Christina Peters
Franz-Martin Fink
Georg Mann
Günter Henze
Helmut Gadner
P304
P356
10.1111/J.1365-2141.2008.07499.X
P407
P577
2008-12-05T00:00:00Z